Cingulate Inc.
General ticker "CING" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $17.1M (TTM average)
Cingulate Inc. follows the US Stock Market performance with the rate: 10.5%.
Estimated limits based on current volatility of 2.8%: low 5.07$, high 5.36$
Factors to consider:
- Total employees count: 13 (0.0%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Limited operating history, Need for additional capital, Unprofitable operations, Regulatory and compliance, Intellectual property risks
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.40$, 9.59$]
- 2026-12-31 to 2027-12-31 estimated range: [1.33$, 5.85$]
Financial Metrics affecting the CING estimates:
- Positive: with PPE of -1.0 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -76.43 <= 0.28
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of 16.64 <= 18.97
Short-term CING quotes
Long-term CING plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $22.76MM | $15.64MM | $19.94MM |
| Operating Income | $-22.76MM | $-15.64MM | $-19.94MM |
| Non-Operating Income | $-0.78MM | $0.10MM | $-2.51MM |
| R&D Expense | $15.49MM | $9.45MM | $9.77MM |
| Income(Loss) | $-23.53MM | $-15.55MM | $-22.45MM |
| Net Income(Loss)* | $-23.53MM | $-15.55MM | $-22.45MM |
| Stockholders Equity | $-6.87MM | $7.46MM | $2.51MM |
| Assets | $3.49MM | $14.86MM | $15.07MM |
| Operating Cash Flow | $-15.03MM | $-18.45MM | $-17.25MM |
| Capital expenditure | $0.22MM | $0.21MM | $0.16MM |
| Investing Cash Flow | $-0.22MM | $-0.21MM | $-0.16MM |
| Financing Cash Flow | $9.95MM | $30.82MM | $16.15MM |
| Earnings Per Share** | $-10.40 | $-4.08 | $-4.13 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.